Literature DB >> 24321053

Multiple eruptive dermatofibromas related to imatinib treatment.

M Llamas-Velasco1, J Fraga, G E Solano-López, J L Steegmann, A García Diez, L Requena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24321053     DOI： 10.1111/jdv.12328

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  2 in total

Review 1.  European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Authors:  J L Steegmann; M Baccarani; M Breccia; L F Casado; V García-Gutiérrez; A Hochhaus; D-W Kim; T D Kim; H J Khoury; P Le Coutre; J Mayer; D Milojkovic; K Porkka; D Rea; G Rosti; S Saussele; R Hehlmann; R E Clark
Journal:  Leukemia       Date:  2016-04-28       Impact factor: 11.528

2.  Multiple Eruptive Dermatofibromas Secondary to Imatinib Mesylate in a Patient with Chronic Myeloid Leukemia.

Authors:  Francisco J Lira-Valero; Liliana Godínez-Aldrete; Nancy Pulido-Díaz; Marissa J Quintal-Ramírez
Journal:  Indian J Dermatol       Date:  2021 Jan-Feb       Impact factor: 1.494
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.